Centiva Capital’s Adtran ADTN Stock Holding History

Centiva Capital’s Portfolio ADTN Stock Details ADTN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-13,716	Closed	-$119K	–	1631
2025 Q4	$119K	Buy	+13,716	New	+$119K	﹤0.01%	1053
2024 Q2	–	Sell	-17,698	Closed	-$96.3K	–	2025
2024 Q1	$96.3K	Buy	+17,698	New	+$113K	﹤0.01%	1610

Other funds holding ADTN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

DnB Asset Management Oslo, Norway $35.7B AUM 27.58% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Centiva Capital's ADTN Position: Q1 2026 in Review

Centiva Capital sold out of Adtran (ADTN) in Q1 2026, closing a stake of 13,716 shares — an estimated $119K sold.

Centiva Capital first reported a position in ADTN in Q1 2024 and held it in 2 quarters. The position peaked at $119K in Q4 2025. 228 funds tracked by Wall St. Rank hold ADTN as of Q1 2026.

Centiva Capital reported no remaining Adtran position as of Q1 2026 after selling out during the quarter.
Centiva Capital sold 13,716 Adtran shares in Q1 2026, an estimated $119K.
Centiva Capital first reported a position in Adtran in Q1 2024 and held it in 2 quarters.
Centiva Capital's Adtran position peaked at $119K in Q4 2025.
228 funds tracked by Wall St. Rank held Adtran as of Q1 2026.

Based on Centiva Capital's 13F filing for Q1 2026, filed 14 May 2026.